Rite Aid Reports Same Store Sales For February

Rite Aid Corporation (NYSE: RAD) today announced sales results for February.

Monthly Sales

For the five weeks ended March 1, 2014, same store sales increased 1.5 percent over the prior-year period. February front-end same store sales decreased 1.8 percent, of which 0.5 percent was attributable to a decrease in sales of flu-related over-the-counter products. Pharmacy same store sales, which included an approximate 138 basis points negative impact from new generic introductions, increased 3.1 percent. Prescription count at comparable stores decreased 1.4 percent over the prior-year period, of which 1.3 percent was attributable to a decrease in flu-related prescriptions.

Total drugstore sales for the five-week period increased 2.4 percent to $2.515 billion compared to $2.457 billion for the same period last year. Prescription sales accounted for 69.1 percent of drugstore sales, and third party prescription sales represented 97.3 percent of pharmacy sales.

Quarterly Sales

Same store sales for the 13-week period ended March 1, 2014 increased 2.1 percent over the prior-year period. Front-end same store sales decreased 0.7 percent while pharmacy same store sales increased 3.5 percent. Prescription count at comparable stores decreased 1.8 percent over the prior-year period.

Total drugstore sales for the 13 weeks ended March 1, 2014 increased 2.2 percent with sales of $6.567 billion compared to $6.425 billion for the same period last year. Prescription sales represented 67.5 percent of total drugstore sales, and third party prescription sales represented 97.1 percent of pharmacy sales.

Year-to-Date

Same store sales for the 52-week period ended March 1, 2014 increased 0.7 percent over the prior-year period. Front-end same store sales decreased 0.2 percent while pharmacy same store sales increased 1.2 percent. Prescription count at comparable stores decreased 0.3 percent over the prior-year period.

Total drugstore sales for the 52 weeks ended March 1, 2014 increased 0.5 percent with sales of $25.411 billion compared to $25.284 billion for the same period last year. Prescription sales represented 67.9 percent of total drugstore sales, and third party prescription sales represented 97.0 percent of pharmacy sales.

If you liked this article you might like

Reworked Deal for Rite Aid Finally Clears FTC

Walgreens Is Primed to Rally, With or Without Rite Aid

S&P 500 and Dow Score Records With Wall Street Upbeat Ahead of Fed

S&P 500 and Dow on Track for Records With Markets in Good Mood Ahead of Fed

Walgreens to Tweak Number of Rite Aid Stores It Buys to Win Regulatory Approval